Lung Infections Double Mortality Risk in Corrected E. coli Genome Study
Genetics

Lung Infections Double Mortality Risk in Corrected E. coli Genome Study

Updated clinical data reveals how bacterial entry routes dramatically alter patient survival odds in bloodstream infections

By Elizabeth Taylor
Published:
Email this Article
Lung Infections Double Mortality Risk in Corrected E. coli Genome Study
Photo by National Institute of Allergy and Infectious Diseases on Unsplash

A detailed correction issued for a genetic study involving 912 patients reveals that bacterial infections entering through the lungs carry a much higher risk of fatal outcomes than previously reported. The updated evaluation shows that pulmonary entry pathways double or nearly triple the odds of death or severe blood poisoning, reshaping how researchers view the impact of bacterial origins on human survival.

The original research, which examined blood samples from patients admitted to teaching hospitals around Paris, sought to connect genetic variations in Escherichia coli bacteria with specific clinical outcomes. Researchers originally miscalculated the prevalence of severe blood poisoning in one of the cohorts by combining generalized sepsis cases with cases of life-threatening septic shock. After correcting this clinical data error, the study authors re-evaluated their statistical models to determine how bacterial genetic traits influence severe infections.

The findings were published in PLoS Genetics, providing a clearer look at how infectious bacteria navigate the human body. The corrected dataset comprises 912 bloodstream infection patients with matching clinical records and whole genome sequences from bacterial isolates. These patients had a median age between 67 and 69 years across the studied cohorts.

How Different Infection Entry Routes Shape Patient Survival

The research team tracked three major patient outcomes, which included death within 28 days, the development of septic shock, and admission to an intensive care unit. Across the combined patient group, urinary and digestive tracts accounted for the vast majority of infection entry points at 58.2 percent and 35.6 percent respectively. Other entry routes accounted for less than 5 percent of cases combined.

Despite the urinary tract being the most common point of entry, it displayed a negative association with patient mortality. Statistical models demonstrated that patients whose infections originated through the urinary tract faced lower odds of dying, with an odds ratio of 0.55. In contrast, infections originating through the pulmonary or lung tract showed a striking increase in danger.

Figure 1
Credit: Denamur E et al. / PLoS genetics

Univariate and multivariate statistical analyses revealed that pulmonary entry was strongly linked to patient mortality with an odds ratio of 2.21. Furthermore, lung-acquired bacterial entry was significantly associated with patients experiencing septic shock, registering an odds ratio of 2.23. Meanwhile, bacterial entry through the digestive tract showed a distinct association with patients requiring intensive care unit admission.

What the Corrected Genetic Data Means for Future Medical Research

Genome-wide association studies look across entire microbial genomes to find genetic markers linked to specific traits. In this investigation, researchers analyzed the core genome phylogenetic tree of the bacterial samples to see if genetic variations determined how the pathogen entered the body or affected patient survival. Despite correcting the clinical data mix-up regarding septic shock rates, the core conclusions of the original genome analysis remained stable and valid.

The authors noted that small variations appeared in the calculated odds ratios, and the overall percentage of patients experiencing septic shock settled at 12.4 percent across both study groups. Reviewers from the journal editorial board confirmed that these statistical adjustments do not undermine the core scientific conclusions regarding bacterial genomics and patient outcomes.

Understanding where an infection enters the human body helps physicians anticipate the severity of a bloodstream infection before critical symptoms escalate. While bacterial genetics play a crucial role in pathogen behavior, clinical variables such as the portal of entry remain dominant predictors of how a patient will fare against a severe infection.

The research was published in PLoS genetics on November 17, 2026.

Fact Checked

This article has been fact checked for accuracy, with information verified against reputable sources. Learn more about us and our editorial process.

Last reviewed on .

Article history

  • Latest version

Reference(s)

  1. Denamur, Erick., et al. “Correction: Genome wide association study of Escherichia coli bloodstream infection isolates identifies genetic determinants for the portal of entry but not fatal outcome.” PLOS Genetics, vol. 22, no. 11, November 17, 2026, pp. e1012374 Public Library of Science (PLoS), doi: 10.1371/journal.pgen.1012374. <https://doi.org/10.1371/journal.pgen.1012374>.

Cite this page:

Taylor, Elizabeth. “Lung Infections Double Mortality Risk in Corrected E. coli Genome Study.” BioScience. BioScience ISSN 2521-5760, 20 November 2026. <https://www.bioscience.com.pk/en/subject/genetics/correction-genome-wide-association-study-of-escherichia-coli-bloodstream-infection-isolates-identifies-genetic-determinants-for-the-portal-of-entry-but-not-fatal-outcome>. Taylor, E. (2026, November 20). “Lung Infections Double Mortality Risk in Corrected E. coli Genome Study.” BioScience. ISSN 2521-5760. Retrieved November 20, 2026 from https://www.bioscience.com.pk/en/subject/genetics/correction-genome-wide-association-study-of-escherichia-coli-bloodstream-infection-isolates-identifies-genetic-determinants-for-the-portal-of-entry-but-not-fatal-outcome Taylor, Elizabeth. “Lung Infections Double Mortality Risk in Corrected E. coli Genome Study.” BioScience. ISSN 2521-5760. https://www.bioscience.com.pk/en/subject/genetics/correction-genome-wide-association-study-of-escherichia-coli-bloodstream-infection-isolates-identifies-genetic-determinants-for-the-portal-of-entry-but-not-fatal-outcome (accessed November 20, 2026).
End of the article